Q3 2017 Holdings
Filed 2017-11-14 | 73 holdings | $30.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $8.6M | 384,145 | 28.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $7.4M | 71,849 | 24.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.3M | 1,193,228 | 20.5% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $2.7M | 135,738 | 8.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $2.6M | 72,226 | 8.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.8M | 325,409 | 6.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $904.0K | 40,000 | 3.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $107.0K | 5,900 | 0.4% |
| Loxo Oncology Inc | COM | 548862101 | $24.1K | 262,121 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.4K | 460,451 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $6.0K | 216,119 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $5.7K | 116,770 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $5.3K | 76,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $4.2K | 346,013 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $4.0K | $4,000,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.5K | 435,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.3K | 54,508 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $3.2K | 718,272 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.2K | 31,609 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.2K | 57,484 | 0.0% |
| Ishares TR Nasdq Biotech(IBB) | ETF | 464287556 | $2.9K | 8,700 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $2.9K | 154,200 | 0.0% |
| Insulet Corp | NOTE 2.000% 6/1 | 45784PAD3 | $2.8K | $2,250,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $2.8K | 57,500 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $2.4K | 117,259 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $2.1K | $2,500,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $2.1K | 53,309 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $2.0K | 75,500 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $1.8K | 52,500 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $1.7K | 349,592 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.7K | 208,458 | 0.0% |
| Uniqure N V(QURE) | SHS | N90064101 | $1.7K | 175,307 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $1.7K | 421,000 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $1.7K | 50,000 | 0.0% |
| Dermira Inc | NOTE 3.000% 5/1 | 24983LAA2 | $1.6K | $1,500,000 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $1.6K | 831,332 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.6K | 105,859 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $1.5K | 37,938 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.4K | 258,667 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $1.3K | 171,094 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $1.3K | 93,800 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $1.2K | 9,400 | 0.0% |
| Scynexis Inc | COM | 811292101 | $1.2K | 506,900 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $1.1K | 79,542 | 0.0% |
| Stereotaxis Inc(STXS) | COM | 85916J409 | $1.1K | 1,372,862 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $1.1K | 443,478 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.1K | 377,695 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $1.0K | 247,000 | 0.0% |
| Clementia Pharmaceuticals in | COM | 185575107 | $1.0K | 60,000 | 0.0% |
| Exactech Inc | COM | 30064E109 | $907 | 27,532 | 0.0% |